Literature DB >> 35373041

Lower Urinary Tract Symptoms Should Be Queried When Initiating Sodium Glucose Co-Transporter 2 Inhibitors.

Nicolas Krepostman1, Holly Kramer2.   

Abstract

Entities:  

Keywords:  SGLT2 inhibitors; adverse effects; aging; chronic kidney disease; diabetes; diuresis; lower urinary tract symptoms; nocturia; thirst; urine output

Mesh：

Substances：

Year:  2021        PMID： 35373041      PMCID： PMC8791328          DOI： 10.34067/KID.0000472021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  10 in total

1.  Lower urinary tract symptoms (LUTS) in males with type 2 diabetes recently treated with SGLT2 inhibitors-overlooked and overwhelming? A retrospective case series.

Authors:  Nino Cristiano Chilelli; Giuseppe Bax; Giulio Bonaldo; Eugenio Ragazzi; Massimo Iafrate; Filiberto Zattoni; Federico Bellavere; Annunziata Lapolla
Journal:  Endocrine       Date:  2017-04-18       Impact factor: 3.633

Review 2.  Nocturia and aging: diagnosis and treatment.

Authors:  Sarinya Boongird; Nirav Shah; Thomas D Nolin; Mark L Unruh
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

3.  SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Brendon L Neuen; Tamara Young; Hiddo J L Heerspink; Bruce Neal; Vlado Perkovic; Laurent Billot; Kenneth W Mahaffey; David M Charytan; David C Wheeler; Clare Arnott; Severine Bompoint; Adeera Levin; Meg J Jardine
Journal:  Lancet Diabetes Endocrinol       Date:  2019-09-05       Impact factor: 32.069

4.  Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.

Authors:  Karen M Hallow; Gabriel Helmlinger; Peter J Greasley; John J V McMurray; David W Boulton
Journal:  Diabetes Obes Metab       Date:  2017-11-15       Impact factor: 6.577

5.  Bladder dysfunction in diabetes mellitus.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  Front Pharmacol       Date:  2010-11-16       Impact factor: 5.810

Review 6.  Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System.

Authors:  Tuba M Ansary; Daisuke Nakano; Akira Nishiyama
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

7.  Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.

Authors:  Takahiro Masuda; Shigeaki Muto; Keiko Fukuda; Minami Watanabe; Ken Ohara; Hermann Koepsell; Volker Vallon; Daisuke Nagata
Journal:  Physiol Rep       Date:  2020-01

8.  Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Clare Arnott; Qiang Li; Amy Kang; Brendon L Neuen; Severine Bompoint; Carolyn S P Lam; Anthony Rodgers; Kenneth W Mahaffey; Christopher P Cannon; Vlado Perkovic; Meg J Jardine; Bruce Neal
Journal:  J Am Heart Assoc       Date:  2020-01-29       Impact factor: 5.501

9.  The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease.

Authors:  Ken Ohara; Takahiro Masuda; Masato Morinari; Mari Okada; Atsushi Miki; Saki Nakagawa; Takuya Murakami; Kentaro Oka; Maki Asakura; Yasuharu Miyazawa; Akito Maeshima; Tetsu Akimoto; Osamu Saito; Daisuke Nagata
Journal:  Diabetol Metab Syndr       Date:  2020-05-01       Impact factor: 3.320

10.  Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.

Authors:  Natalie A Mordi; Ify R Mordi; Jagdeep S Singh; Rory J McCrimmon; Allan D Struthers; Chim C Lang
Journal:  Circulation       Date:  2020-08-29       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.